We next sought to determine whether the TLX-induced downregulation of AR expression in prostate cancer cells could be mediated by its direct transrepression of AR gene expression or indirectly via other TLX-controlled downstream signaling pathways. The gene discussed is AR; the disease is prostate cancer.